Anavex Life Sciences Corp (AVXL)

[sage4]

Anavex at 2020 Epilepsy Pipeline Conference
Mar 12-14 in Santa Clara, Calif

Hope the conference is not canceled due to Corona-19.

Edit- Just checked and it is postponed. No date yet

-------------------------------------------------------------
Day 2 Mar-13
Session IX Continued: Rare And Ultra-Rare Diseases – 1:20-3:20 P.M.
KB-3061, Knopp Biosciences – Steven Dworetzky PhD, Vice President of Discovery Research
Tak-935/OV935, Takeda Pharmaceuticals – Mahnaz Asgharnejad PharmD, Vice President of Clinical Development
UX-068, Ultragenyx – Melanie Brandabur MD, Medical Director
VAL-0417 and VAL-1221, Valerion Therapeutics – Matthew Gentry PhD
XEN-496, Xenon Pharma – Ernesto Aycardi, Chief Medical Officer
ZX008, Zogenix – Glenn Morrison PhD, Vice President of Global Clinical Development
Anavex 2-73, Anavex Life Sciences – Walter Kaufmann MD, Chief Medical Officer
AE116, Aeovian Pharmaceuticals– Stelios Tzannis PhD, President & CEO
Natalizumab, Biogen – Kim Parkerson MD, PhD, Medical Director, Epilepsy and Neurodevelopment
PRAX-330, Praxis Precision Medicines – Kiran Reddy MD
NBI-921352, Neurocrine Biosciences – Dietrich Haubenberger MHSc, MD, Medical Director, Early Clinical Development
Epidiolex for Tuberous Sclerosis, Greenwich Biosciences – Farhad Sahebkar MD, Senior Medical Director